A detailed history of Sabadell Asset Management, S.A S.G.I.I.C transactions in Boston Scientific Corp stock. As of the latest transaction made, Sabadell Asset Management, S.A S.G.I.I.C holds 182,274 shares of BSX stock, worth $16.5 Million. This represents 2.03% of its overall portfolio holdings.

Number of Shares
182,274
Previous 109,619 66.28%
Holding current value
$16.5 Million
Previous $5.56 Billion 75.46%
% of portfolio
2.03%
Previous 1.18%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jan 23, 2024

BUY
$49.72 - $54.64 $3.61 Million - $3.97 Million
72,655 Added 66.28%
182,274 $9.76 Billion
Q1 2023

Jan 23, 2024

BUY
$45.09 - $50.03 $4.94 Million - $5.48 Million
109,619 New
109,619 $5.56 Billion
Q2 2022

Jan 23, 2024

SELL
$35.24 - $47.1 $3.91 Million - $5.23 Million
-111,074 Closed
0 $0
Q2 2021

Jan 23, 2024

BUY
$38.58 - $44.24 $4.29 Million - $4.91 Million
111,074 New
111,074 $4.75 Billion

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Sabadell Asset Management, S.A S.G.I.I.C Portfolio

Follow Sabadell Asset Management, S.A S.G.I.I.C and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sabadell Asset Management, S.A S.G.I.I.C, based on Form 13F filings with the SEC.

News

Stay updated on Sabadell Asset Management, S.A S.G.I.I.C with notifications on news.